11:24
2026-09-09
fortune.com
artificial-intelligence
Insilico’s co-CEO hopes ‘we might have a chance to stop biological aging’ after promising results from its fibrosis drug trial
Insilico Medicine co-CEO Feng Ren said the company's experimental fibrosis drug reduced patients' predicted biological age by roughly three years on average, and up to six years on one measure, raisin…